Research Overview: Hypho-Viagra Beligas
Hypho-Viagra Beligas is a phosphodiesterase-5 (PDE5) inhibitor containing sildenafil citrate as the active pharmaceutical ingredient. This selective enzyme inhibitor has been extensively investigated in laboratory studies examining vascular physiology, nitric oxide signalling pathways, and cellular cyclic nucleotide dynamics. Research institutions worldwide have utilised sildenafil citrate preparations to examine endothelial function, smooth muscle relaxation mechanisms, and cardiovascular adaptation responses in controlled experimental settings.
Laboratory Applications
Researchers at Stroid UK Shop investigate Hypho-Viagra Beligas for its well-documented effects on cyclic guanosine monophosphate (cGMP) pathways. Studies examine how PDE5 inhibition affects vascular reactivity, platelet aggregation, and pulmonary circulation dynamics in animal models. The compound’s selectivity for PDE5 over other phosphodiesterase isoforms makes it valuable for isolating specific enzymatic pathways in biochemical research. Laboratory studies have evaluated its effects on exercise capacity, hypoxic pulmonary vasoconstriction, and cardiac adaptation mechanisms. Research applications extend to examining endothelial dysfunction models, investigating nitric oxide bioavailability, and studying the role of cGMP signalling in various physiological processes. Scientists studying erection dysfunction research compounds frequently utilise this preparation alongside other vascular modulators. Advanced research protocols examine interactions with other signalling pathways, particularly those involving selective androgen receptor modulators and research peptides in comprehensive experimental designs.
Compound Specifications
| Active Ingredient | Sildenafil Citrate |
|---|---|
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Classification | PDE5 Inhibitor |
| Storage Conditions | Room temperature, dry environment |
Research Compliance
This product is manufactured by Beligas Pharmaceuticals exclusively for in-vitro research applications and laboratory studies. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate safety protocols and institutional oversight when handling this compound.
